A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

NCT00683969 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis, Generalized

Interventions

DRUG: mycophenolate mofetil (CellCept)
DRUG: placebo

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]